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Viral regulatory regionuence the oncogenic potential of polyomavirus simian virus 40 (SV40). We
hypothesized that viral strain differences might also affect vertical transmission of SV40 in susceptible hosts.
Pregnant Syrian golden hamsters were inoculated intraperitoneally with 107 plaque-forming units of SV40
and offspring were sacriﬁced post-delivery (1–21 days, 6 months). Organ extracts were analyzed for SV40
DNA by polymerase chain reaction assay. Transmission of SV40 frommother to offspring was detected in over
half of litters. Most placentas were virus-positive. Mothers inoculated with SV40 strains containing complex
regulatory regions transmitted virus more frequently than those infected with simple enhancer viruses
(pb0.001). Virus was detected more often in progeny brain than in spleen (pb0.05). Several progeny were
virus-positive at 6 months of age, suggesting viral persistence. Maternal animals retained virus in several
tissues through day 21 and developed T-antigen antibodies. These results indicate that SV40 replicates in
hamsters, vertical transmission of SV40 can occur, and the viral regulatory region inﬂuences transmission.
© 2009 Elsevier Inc. All rights reserved.IntroductionVertical transmission of various DNA and RNA viruses among
humans (Blanche et al., 1989; Candotti et al., 2006; Demmler, 1991;
Paisley et al., 2006; Paryani and Arvin, 1986; Pereira et al., 2005;
Stevens et al., 1975) and animals (Amedee et al., 1995; McCance and
Mims, 1977; Oldstone and Dixon, 1972; Zhang et al., 2005) is well
documented. Murine polyoma virus has been implicated in intrauter-
ine infections in mice (McCance and Mims, 1977; Zhang et al., 2005).
However, the potential for this mode of transmission among other
members of the family Polyomaviridae is less clear. Transplacental
transmission of BK virus (BKV) has been suggested based on detection
of BKV DNA in fetal tissues (Pietropaolo et al., 1998), but others failed
to detect evidence of transmission (Boldorini et al., 2008). Studies
based on assays for IgM class antibody to BKV and JC virus (JCV) in
umbilical cord blood samples found no evidence for congenital
transmission (Andrews et al., 1983; Brown et al., 1984). Simian virus1762@bcm.edu (A.S. Arrington),
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l rights reserved.40 (SV40), a polyomavirus of macaque origin, was introduced into
humans presumably as a result of the widespread use of poliovaccines
inadvertently contaminated with this DNA virus (Butel and Lednicky,
1999; Cutrone et al., 2005; Stratton et al., 2003; Vilchez and Butel,
2004). The contamination occurred because vaccines were produced
in cultures of kidney cells derived from rhesus macaques, which are
frequently infectedwith SV40. As infectious SV40 survived the vaccine
inactivation treatments in early killed (Salk) vaccines and was present
in live (Sabin) vaccines, millions of people were exposed to live SV40
(Butel and Lednicky, 1999; Cutrone et al., 2005; Proceedings of the
Second International Conference on Live Poliovirus Vaccines, 1960;
Stratton et al., 2003; Vilchez et al., 2003; Vilchez and Butel, 2004).
SV40 infections have been detected in different human popula-
tions today (Butel, in press; Vilchez and Butel, 2004). Signiﬁcantly,
some of the subjects found with SV40 markers were not exposed to
contaminated poliovaccines, suggesting infections by other pathways
(Butel et al., 1999a; Stratton et al., 2003; Vilchez and Butel, 2004).
Maternal–infant transmission has been reported as a possible route of
polyomavirus SV40 pathogenesis in the hamster model (Rachlin et al.,
1988). This might also represent a pathway for occasional transmis-
sion of SV40 in humans, as SV40 large tumor antigen (T-ag) DNA or
protein has been detected in primary brain and bone cancers in infants
and young children (Bergsagel et al., 1992; Lednicky et al., 1995a;
Malkin et al., 2001; Martini et al., 1996; Stewart et al., 1998; Suzuki et
al., 1997; Weggen et al., 2000; Zhen et al., 1999). In addition, SV40 has
been isolated (Brandner et al., 1977; Lednicky et al., 1995a) and
Fig. 1. Quantitative assay for hamster vimentin gene. (A) A representative hamster vi-
mentin gene ampliﬁcation plot of normalized reporter ﬂuorescence (ΔRn) against the
cycle number. The log10 of the input copy number of each plasmid standard is indicated.
NTC, Non-template control. (B) Typical standard curve for the hamster vimentin gene
created by regression analysis of the observed CT value against the log10 of the input
copy number of standard plasmid DNA encoding the vimentin gene sequences.
R2=0.9991; y=3.3295x+40.579.
Table 1
Vertical transmission of SV40 from maternal hamsters inoculated during pregnancy to
progeny animals1
Days
after
birth
Viral strain
(no. positive litters)a
No.
progeny
tested
Tissue No. tissues
positive/
no. tested (%)b
Viral loads
(copies/106 cells)
range (mean)c
1, 3 Baylor-2E (2) 30 Kidney 1/29 (3) 649 (649)
Lung 3/30 (10) 234–1944 (1192)
7 Baylor-1E (1) 23 Spleen 4/21 (19) 817–2406 (1452)
SVCPC (2) Kidney 1/20 (5) 23,966 (23,966)
Lung 4/19 (21) 488–2532 (1623)
Brain 0/17 (0) b5 (b5)
14 SVCPC (1) 22 Spleen 1/22 (5) 1020 (1020)
SVPML-1 (1) Kidney 0/22 (0) b5 (b5)
Lung 0/20 (0) b5 (b5)
Brain 4/22 (18) 477–908 (719)
21 SVPML-1 (1) 12 Spleen 0/12 (0) b5 (b5)
Kidney 1/10 (10) 376 (376)
Lung 0/12 (0) b5 (b5)
Brain 2/12 (17) 477–893 (685)
1 Pregnant hamsters were inoculated intraperitoneally with 107 PFU of SV40.
a Vertical transmission was not detected in litters from 6 additional animals
inoculated with SV40 strains Baylor-1E, Baylor-2E, SVCPC, and SVPML-1 and harvested
at 3, 7/14/21, 21, and 7 days after birth, respectively (data not shown).
b One tissue slice per organ was analyzed for SV40 DNA.
c Viral loads among virus-positive samples.
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(Vanchiere et al., 2005a) from young children.
Different natural strains of SV40 have been recognized (Forsman et
al., 2004) and appear to be distributed in the human population (Butel
and Lednicky, 1999; Forsman et al., 2004; Stewart et al., 1998). Strains
of SV40 are known to diverge in the structure of their regulatory
region and some strains have variants based on the number of
enhancer elements in this region (Lednicky and Butel, 2001; Stewart et
al., 1998). SV40 variants containing two 72-base-pair enhancer
elements or other sequence rearrangements or duplications are said
to have complex regulatory region structures; those with one
enhancer and no rearrangement have a simple regulatory region
structure (Lednicky and Butel, 2001; Stewart et al., 1998). The number
of enhancer elements in the regulatory region of SV40 inﬂuences the
replication of the virus in cell cultures (Lednicky et al., 1995b; Lednicky
and Butel, 2001). This report describes investigations that quantify
vertical transmission of polyomavirus SV40 in the hamster model,
identify infected tissues, reveal the potential contribution of the
structure of the SV40 regulatory region on transmission of virus from
mothers to offspring, and suggest that persistent infectionsmay occur.
Results
Absolute quantiﬁcation of hamster vimentin gene in real-time
quantitative polymerase chain reaction (RQ-PCR) assays
The vimentin gene is a proven hamster single copy gene. The
ampliﬁcation of this gene serves as a control for the quality of cellular
DNA isolated from hamster tissues. The quantitative analysis of the
vimentin gene allows SV40 copy numbers to be normalized to cell
numbers. The standard curve method of analysis was used for
absolute quantiﬁcation of the vimentin gene in RQ-PCR assays. Arepresentative ampliﬁcation plot of serial 10-fold dilutions of the
vimentin standard plasmid is shown in Fig. 1A. The lower limit of
reproducible detection of the vimentin standard in multiple assays
was 101 copies of the target gene; in a few assays, 100 copy was
detected. Standard curves were generated to allow calculation of
amounts of the vimentin gene in experimental samples (Fig. 1B).
The precision of ampliﬁcation of the vimentin target gene was
assessed by measuring known quantities of two hamster lymphoma
cell lines (McNees et al., 2009). The RQ-PCR assay was sensitive and
reproducible up to 5×105 cell equivalents/reaction. Generally, 250–
500 ng of input cellular DNA (representing approximately 37,000–
75,000 cells) was used per reaction in assays of experimental samples,
well within the limits of the assay.
Transmission of SV40 from mothers to offspring hamsters
A total of 14 pregnant Syrian golden hamsters were inoculated
with SV40 strains and 6 with uninfected cell lysate as controls.
Mothers and offspring were sacriﬁced 1, 3, 7, 14, and 21 days post-
parturition (Table 1). Multiple organs were harvested from mothers
and offspring from the inoculated and control groups and total DNA
was extracted. A total of 127 progeny yielding 403 organs were
produced from 14 virus-inoculated pregnant hamsters; 73 progeny
(259 organs) were produced from the control animals. One tissue slice
per organ was analyzed by RQ-PCR. Vimentin gene sequences were
ampliﬁed from all samples tested. SV40 DNA was detected in tissues
(spleen, kidney, lung, brain) from some offspring (Table 1). The mean
SV40 viral loads in progeny animal tissues were variable, ranging from
376 to 23,966 copies/106 cells in positive tissues. A total of 8 of 14
(57%) litters, 18 of 127 (14%) progeny, and 21 of 403 (5%) organs were
positive for SV40 from progeny in the inoculated group, compared to
none (0 of 6 litters, 0 of 73 progeny, and 0 of 259 organs) in the control
group (Table 2). From all offspring tested from 1 to 21 days of age,
positive tissues detected were spleen (n=5), kidney (n=3), lung (n=7),
and brain (n=6) (Table 1).
The dynamics of infection in progeny animals with different strains
of SV40 are shown (Table 2). However, comparable harvests were not
available for all viral strains at some time points. A litter was
considered to be positive if SV40 DNA was detected in one littermate.
Overall, 8 of 14 (57%) litters from mothers in the SV40-inoculated
group were infected, as compared to none in the control group
(p=0.02). Positive litters ranged from a single animal that contained
Table 2
Dynamics of detection of SV40 vertical transmission1
Strain/variant No. litters positive/no. tested (%) No. progeny positive/no. testeda (SV40 copies/106 cells)b Total (%)
1, 3 days after birth 7 days after birth 14 days after birth 21 days after birth
Baylor-1E 1/2 (50) 0/7 (b5) 1/12 (488) NDc ND 1/19 (5)
Baylor-2E 2/5 (40) 4/23 (303) 0/14 (b5) 0/6 (b5) 0/5 (b5) 4/48 (8)
SVCPC 3/4 (75) ND 5/11 (4473) 1/10 (908) 0/9 (b5) 6/30 (20)
SVPML-1 2/3 (67) ND 0/6 (b5) 4/12 (747) 3/12 (582) 7/30 (23)
Total (%): 8/14 (57) 4/30 (303) 6/43 (2883) 5/28 (799) 3/26 (582) 18/127 (14)
Control 0/6 (0) 0/8 (b5) 0/22 (b5) 0/24 (b5) 0/19 (b5) 0/73 (0)
1 Pregnant hamsters were inoculated intraperitoneally with 107 PFU of SV40. From Table 1.
a One tissue slice per organ (spleen, kidney, lung, brain) was analyzed for SV40 DNA for each animal.
b Mean viral loads among virus-positive samples.
c ND, not done.
Table 3
Frequency of SV40 vertical transmission to progeny animals is higher from mothers
inoculated with SV40 variants with complex regulatory region structures1
Type of
regulatory
region
Strain/variant No. litters
positive/
no. tested (%)
No. progeny
positive/
no. tested (%)a
No. tissues
positive/
no. tested (%)a
Simple Baylor-1E 0/1 (0) 0/12 (0) 0/36 (0)
SVCPC 1/1 (100) 2/8 (25) 3/14 (21)
Total: 1/2 (50) 2/20 (10)b 3/50 (6)c
Complex Baylor-2E 1/1 (100) 13/14 (93) 23/39 (59)
SVPML-1 1/1 (100) 6/6 (100) 16/18 (89)
Total: 2/2 (100) 19/20 (95)b 39/57 (68)c
1 Analysis of litters harvested 7 days after birth.
a Three tissue slices for each of three different organs (spleen, kidney, brain) were
analyzed for SV40 DNA for each animal.
b pb0.001.
c pb0.001.
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difference in mean viral loads observed among time points was not
statistically signiﬁcant because of small sample sizes.
Structure of the SV40 regulatory region and vertical transmission
In vitro studies have shown that SV40 isolates with a complex
regulatory region produced higher virus yields and larger plaque sizes
in cultured cells than did viruses with a simple regulatory region
(Lednicky et al., 1995b; Lednicky and Butel, 2001). Hamster experi-
ments demonstrated that SV40 strains with simple (1E) regulatory
region structures weremore oncogenic than strainswith complex (2E)
regulatory regions (Sroller et al., 2008). However, signiﬁcantly more of
the tumor-free hamsters exposed to 2E viruses developed antibodies
to T-ag than did the non-tumor-bearing animals inoculated with 1E
strains, suggesting more abundant replication of SV40 strains with
complex regulatory regions in the animals (Sroller et al., 2008). These
observations provided the rationale for examining whether SV40
strains with different regulatory region structures diverged in their
frequency of transmission. All SV40 strains tested had resulted in
vertical transmission (Table 1). To explore possible regulatory region
effects on transmission in more detail, 4 litters harvested at 7 days
after birth were analyzed further (Table 3). In this analysis, multiple
tissue sections (3 tissue slices per organ per progeny) were assessed
for the presence of SV40 DNA. Of mothers inoculated with SV40
strains containing simple regulatory regions (Baylor-1E and SVCPC),
transmission occurred in 1 of 2 (50%) litters, and virus was detected in
2 of 20 (10%) progeny and 3 of 50 (6%) tissues. In contrast, in offspring
of mothers inoculated with SV40 strains containing complex
regulatory regions, 2 of 2 (100%) litters, 19 of 20 (95%) progeny, and
39 of 57 (68%) tissues were virus-positive. This difference between
SV40 1E and 2E variants was statistically signiﬁcant (pb0.001), with
the transmission rate for 2E viruses being approximately 65% greater
than for 1E variants. SV40 DNA was preferentially detected in brain
tissue of progeny compared to spleen (pb0.05), but there was no
difference between spleen and kidney (pN0.60) for virus detection.
A long-term experiment was conducted to examine the possibility
of persistent infection by SV40 in offspring of inoculated mothers.
Three litters of progeny hamsters were removed from their mothers at
day 21 and were held for 6 months after birth (Table 4). The animals
from given litters were caged together. Results showed that 6 of 14
(43%) animals were SV40-positive, with SV40 viral loads ranging from
518 to 3539 copies/106 cells in positive tissues. Viral DNAwas detected
in lung and spleen tissues in 7 of 36 (19%) tissues of progeny from
SV40-injected mothers. Tumors did not develop in any of the progeny
animals in the short- or long-term experiments.
Distribution of SV40 in maternal hamster tissues
SV40 was detected in tissues from all virus-inoculated mother
hamsters that were tested except two; those two animals from theBaylor-2E group (and another animal from the SVCPC group that was
not tested) are not shown (Table 5). Results from eight animals
injected with virus variants containing simple regulatory regions and
eight animals with variants having complex regulatory regions are
reported (Table 5). Maternal animals were sacriﬁced at the same times
as their litters, ranging from 2 to 24 days postinoculation (p.i.) (either
before delivery or from 3 to 21 days after delivery), maternal tissues
were collected, and total DNAs were extracted. Viral loads were
assayed in three organs (spleen, kidney, lung). Viral loads were low at
2 days p.i. (3270 copies/106 cells or less), were highest in tissues from
animals sacriﬁced 4 and 6 days p.i., reaching over 600,000 copies/106
cells (animals 4, 9, 10), and declined by 10 to 24 days p.i., but remained
detectable in spleen and kidney. In contrast, infections often had been
cleared from the lungs at the later timeswith detectable levels of SV40
remaining in only 3 of 9 animals. Blood was available from 9 animals.
Virus was detected in white blood cells (WBCs) soon after infection
and persisted, at least in two animals, up to 17 and 24 days p.i. Virus
was also detected in plasma, but at very low levels (usually less than
50 genome copies per 10 μl). The amount of virus present in blood
samples did not appear to correlate with SV40 viral loads detected in
the maternal tissues of the same animals, suggesting that tissue-
associated virus did not reﬂect simple presence of circulating blood-
associated virus. No virus was found among hamsters in the control
group of 8 animals (data not shown).
Potential for transplacental transmission of SV40
As vertical transmission of SV40 in progeny hamsters could have
occurred either before, during, or after birth, the possibility of
transplacental transmission was examined. Two groups of pregnant
hamsters were inoculated with SV40 strains Baylor (variant 1E) and
776-2E; a control animal was inoculated with uninfected cell lysate.
Pregnant hamsters were sacriﬁced prior to delivery (48 h p.i. to 6 days)
Table 4
Evidence of SV40 vertical transmission and persistence of virus in progeny animals
6 months after birth
Strain/variant
(regulatory
region)
No of litters
positive/
no. tested
(%)
No. progeny
positive/
no. tested
(%)
Tissue No. tissues
positive/
no. tested
(%)
Viral load
(copies/106 cells)
Range
(mean)a
SVCPC 1/1 (100) 1/5 (20) Spleen 1/1 (100) 2343 (2343)
(simple) Kidney 0/5 (0) b5
Lung 0/5 (0) b5
776-2E 1/2 (50) 5/9 (56) Spleen 1/7 (14) 615 (615)
(complex) Kidney 0/9 (0) b5
Lung 5/9 (56) 518–3539 (1800)
Total: 2/3 (67) 6/14 (43) 7/36 (19) 518–3539 (1721)
a Viral loads among virus-positive samples.
Table 6
Infection of placental tissue in hamsters by SV40
SV40 strain/
variant
No. litters positive/
no. tested (%)
Placentas
No. positive/
no. tested (%)
Viral loads (copies/106 cells)
Range (mean)a
Baylor-1Eb 0/3 (0) 21/23 (91) 233–8010 (3670)
776-2Ec 1/2 (50) 2/2 (100) 27,400–148,000 (87,700)
Total: 1/5 (20) 23/25 (92) 233–148,000 (11,000)
Control 0/1 (0) 0/12 (0) b5 (b5)
a Viral loads among virus-positive samples.
b Harvested 2 days p.i., prior to delivery.
c Harvested 6 days p.i., prior to delivery.
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as described in Materials and methods. Placentas were frequently
virus-positive (23 of 25, 92%) and were found only among the SV40-
inoculated group (Table 6). Mean SV40 viral loads in virus-positive
placentas were 11,000 copies/106 cells. Viral loads were higher in
placentas from animals exposed to strain 776-2E, as compared to
those inoculated with Baylor-1E. SV40 DNA was detected in 4 of 47
(8.5%) fetuses from 1 of 5 litters tested from SV40-infected mothers,
suggesting the possibility of transplacental transmission. The positive
litter was from an animal inoculated with strain 776-2E. No virus was
detected in fetuses of the uninfected animals.
SV40 antibody responses in mothers and offspring
Serologic responses to SV40 were determined for mothers and
offspring in the inoculated and control groups. Maternal hamsters
from SV40-inoculated groups that were sacriﬁced between 10 and
24 days p.i. were tested for virus neutralizing antibodies and all were
positive. Median neutralizing titers for animals inoculated with SV40
strains SVCPC (n=3), SVPML-1 (n=3) and Baylor-2E (n=3) were 1:100,
1:1000, and 1:1000, respectively. Some of the tested mothers from the
virus-inoculated groups also had detectable T-ag antibody responses.
Positivity rates and median T-ag antibody titers for the different
groups of maternal hamsters were the following: SVCPC, 3 of 4
positive (1:100); SVPML-1, 2 of 3 positive (1:5); Baylor-2E, 2 of 3
positive (1:5); and 776-2E, 1 of 1 positive (1:10). None of the maternalTable 5
Viral loads in maternal tissues and blood following inoculation of pregnant hamsters with S
Animal number Type of regulatory region Strain/variant Days post-inoculat
(days post-delivery
1 Simple Baylor-1E 2a
2 2a
3 2a
4 6 (3)
5c 10 (7)
6c SVCPC 10 (7)
7c 17 (14)
8 24 (21)
9c Complex Baylor-2Ed 4 (1)
10c 6 (3)
11c 10 (7)
12 17 (14)
13 24 (21)
14c SVPML-1 10 (7)
15c 17 (14)
16c 24 (21)
a Animals from transplacental transmission experiments.
b ND, not done.
c Animals with virus-positive offspring.
d Two animals inoculated with SV40 strain Baylor-2E and harvested 2 days p.i. were negati
harvested at 10 days p.i. was not tested (data not shown).animals from the control group (n=5) had serologic evidence of SV40
infection. None of 12 progeny animals harvested at the 21-day
timepoint had detectable virus neutralizing antibodies.
Discussion
Vertical transmission of a virus to the fetus may occur during the
birth process, in the period soon after birth, or across the placenta
prior to birth (Virgin, 2007). The studies described here involving
Syrian golden hamsters indicate that vertical transmission is a
possible mode of spread of polyomavirus SV40. These are intriguing
ﬁndings as SV40 DNA has been detected in infants (Bergsagel et al.,
1992) and recent reports have indicated that the virus is shed in the
urine (Vanchiere et al., 2005b) and stool (Vanchiere et al., 2005a) of
young children. The overall rates of SV40 transmission from mothers
to individual offspring in the hamster model under our experimental
conditions averaged 14%, a value comparable to those of varicella–
zoster virus and human immunodeﬁciency virus vertical transmission
in humans (2–20% and 13–30%, respectively) (Blanche et al., 1989;
Paryani and Arvin, 1986), but higher than those reported for
cytomegalovirus and West Nile virus in humans (0.2% to 4%,
respectively) (Demmler, 1991; Paisley et al., 2006). The frequency of
SV40-positive litters following inoculation of pregnant hamsters was
high at 57% (8 of 14 litters with one or more positive progeny).
This study was not designed to study transplacental transmission
in detail, but we did detect virus transmission in 1 of 5 litters. This wasV40 strains with different regulatory region structures
ion
)
SV40 copies/106 cells Blood
Spleen Kidney Lung WBC (SV40
copies/106 cells)
Plasma (SV40
copies/10 μl)
255 1770 869 NDb 41
1590 3270 3020 10,400 22
b5 360 891 962,000 12
11,300 8020 609,000 b5 b5
72 559 b5 ND ND
2460 25,000 b5 ND ND
8680 17,800 b5 ND ND
3670 32,900 b5 ND ND
233,000 789,000 442,000 ND 580
45,400 883,000 72,200 ND 17
17,500 34,400 1780 b5 16
26,100 44,400 1470 20,600 14
409 3890 b5 383,000 b5
7040 36,900 769 ND ND
3180 11,900 b5 ND ND
249 810 b5 ND ND
ve for SV40 DNA in all tissues tested; one animal inoculated with SV40 strain SVCPC and
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86%) (Zhang et al., 2005), perhaps reﬂecting differences in experi-
mental conditions or in maternal or viral factors that affect the
establishment of infection. One difference is that the Syrian golden
hamsters are outbred, making it likely that they exhibit broader
individual variations in susceptibilities to infection than inbred mice.
Although it was assumed in the past that hamsters are non-
permissive hosts for SV40, recent evidence indicates that SV40 can
infect and undergo replication in some hamsters. In a previous study,
infectious SV40 was rescued from 39% of tumor cell lines established
from primary tumors induced by SV40 (Sroller et al., 2008). Tumors
fromwhich the cell lines were established had arisen 5–8 months p.i.,
making it highly unlikely that residual input SV40 was resident in the
tumors in vivo and survived during subculture of the cell lines in vitro.
This observation was compatible with earlier reports of recovery of
infectious virus and/or infectious viral DNA from SV40 tumor cells
(Black and Rowe, 1964; Boyd and Butel, 1972; Gerber, 1964; Sabin and
Koch, 1963). Many virus-inoculated, tumor-free animals developed
antibodies to T-ag that persisted for one year following either
intraperitoneal or intravenous exposure (McNees et al., 2009; Sroller
et al., 2008). The percentage of T-antibody responders among tumor-
free hamsters was higher for those inoculated with viruses having
complex regulatory regions as compared to those with simple
enhancers. We believe induction of durable T-antibodies in the
absence of tumor formation reﬂects synthesis of T-ag during virus
infection and that viruses with complex enhancers replicate more
abundantly in vivo than thosewith simple enhancers. SV40 regulatory
region rearrangements were detected in several SV40-induced tumors
(Sroller et al., 2008), and it has been proposed that such rearrange-
ments reﬂect recombination during viral DNA replication (Cubitt,
2006; Yogo and Sugimoto, 2001). In this study, SV40 strains with
complex regulatory regions were vertically transmitted signiﬁcantly
more frequently than strains with simple enhancers. Our interpreta-
tion is that the 2E viruses replicated to higher titers, increasing the
likelihood of transmission. Maternal animals exhibited a rise in viral
load from day 2 p.i. followed by viral persistence in maternal spleen,
kidney and WBCs through day 24 (the latest time point examined),
plus the production of anti-T-ag antibodies. These analyses provided
evidence of SV40 replication in hamsters and identiﬁed tissues that
can be virus positive following IP inoculation.
We postulate that higher viral loads in the mother increase the
potential for vertical transmission of polyomavirus. There was a
statistically signiﬁcant higher frequency of transmission of virus to
progeny from mothers infected with virus with complex enhancer
structures than with simple enhancers (Table 3). The frequent
detection of SV40 DNA in brain tissue of progeny is compatible with
other studies suggesting that SV40 can be neurotropic (Bergsagel et
al., 1992; Lednicky et al., 1995a; Lednicky and Butel, 2001).
The SV40-infected maternal hamsters had detectable virus in
tissues that might serve as sources of virus for transmission to their
young after birth, including the kidney (urine) and lung (respiratory
droplets). It is of interest that lung tissue was sometimes positive in
progeny animals, raising the possibility that some polyomavirus
infections might occur via the respiratory route. It is expected that
blood would be the route of fetal infection in utero. Compatible with
that premise, SV40 was detected in the blood of maternal hamsters. It
is noteworthy that in the case in which transplacental transmission
was documented, there had been a longer duration p.i. prior to fetal
harvest than in the other litters tested. In addition, the placentas from
that litter had signiﬁcantly higher viral loads than those from litters in
which transmission was not detected, suggesting that placental viral
loads may impact transmission to the fetus or may reﬂect overall viral
loads in those maternal animals.
Any long-term effects of SV40 vertical transmission in progeny
animals were not addressed in this study. However, none of 43
animals held for 6 months developed neoplasms. This ﬁndingcontrasts with a previous report that 43–54% of progeny from SV40-
inoculated pregnant hamsters developed tumors (Rachlin et al., 1988).
There were several differences between the two studies that may
explain the results. The hamsters were obtained from different
sources, the pregnant animals were inoculated earlier during gesta-
tion in the Rachlin study than in ours, and they observed the animals
for 10 months as compared to only 6 months in our study. SV40 tumor
latency and tumor frequency are virus-dose dependent (Gerber and
Kirschstein, 1962; Girardi et al., 1963). It is possible that earlier
gestational inoculation led to higher amounts of virus being
transmitted to the fetuses in the Rachlin study, increasing their
effective exposure dose; that exposure, coupled with the longer
period of observation, perhaps made it more likely that tumors could
be observed.
Our ﬁndings of SV40 vertical transmission in the hamster model
differ from cross-sectional serological surveys in captive rhesus
macaques (Minor et al., 2003) and humans (Engels et al., 2004) that
suggested that vertical transmission had not occurred. Serologic
analyses of BKV in humans led to the conclusion that transplacental
transmission was not a mode of spread for this polyomavirus
(Andrews et al., 1983; Brown et al., 1984). Recent molecular-based
studies have differed in evidence for transplacental transmission of
human polyomaviruses (Boldorini et al., 2008; Pietropaolo et al.,
1998). Additional studies are warranted to clarify the possible vertical
transmission of polyomavirus in humans.
It is known that SV40 strains may have different growth properties
in vitro (Lednicky et al., 1995b; Lednicky and Butel, 2001) and recent
observations have proven variation in oncogenic potential in vivo
(Sroller et al., 2008; Vilchez et al., 2004). This study shows that viral
strains can differ in the biologic property of frequency of vertical
transmission, as well. All three examples reﬂected differences in the
regulatory region structures of the viral variants. This suggests that
the viral regulatory region can be considered a determinant that may
affect pathogenesis of infection and disease in vivo.
Animal models have been powerful experimental tools for studies
of human disease pathogenesis, including cancer (Mizgerd and
Skerrett, 2008; Virgin, 2007). Syrian golden hamsters are uniquely
susceptible to a variety of intracellular pathogens. They serve as
infection models that mimic human disease for several parasites,
including Leishmania (Melby et al., 2001) and Opistorchis (Jittimanee
et al., 2007). Hamsters are permissive immunocompetent animal
models for infections by numerous viruses able to infect humans,
such as herpesviruses (van Ekdom et al., 1987), vaccinia virus (Nelles
et al., 1981), adenovirus (Thomas et al., 2006), rubella virus (Rayﬁeld
et al., 1986), measles virus (Vanchiere et al., 1995), Nipah virus
(Wong et al., 2003), arenaviruses (Gowen et al., 2005), ﬂaviviruses
(Siirin et al., 2007; Tesh et al., 2005), and hantaviruses (Campen et
al., 2006). As described above, it appears that SV40 can replicate in
hamsters. SV40 has long been recognized for its ability to induce
tumors in hamsters (Butel et al., 1972; Butel, 2000; Butel and
Lednicky, 1999; Cicala et al., 1992; Diamandopoulos, 1973) and the
types of tumors that develop include the same spectrum of
malignancies as the human cancers associated with SV40 (Butel, in
press; Gazdar et al., 2002). The hamster model has shown that
asbestos and SV40 can cooperate in induction of mesotheliomas
(Kroczynska et al., 2006). Similarities have been found between
humans and hamsters with respect to tissues that can harbor SV40
and the spectrum of malignancies associated with the virus.
Hamsters are especially well-suited for future comparative studies
of the effects of viral strain genetic differences on pathogenesis of
SV40 infections and disease.
In conclusion, the results described here show that vertical
transmission by polyomavirus SV40 can occur in susceptible hosts,
that the viral regulatory region is a determinant of transmission, and
that SV40 appears to replicate in hamsters. The possibility of vertical
transmission of polyomaviruses in humans should be considered.
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Experimental animals
Outbred female and male Syrian golden hamsters (Mesocricetus
auratus) were obtained from Harlan Sprague Dawley, Indianapolis, IN.
Pregnant hamsters were inoculated intraperitoneally at late gestation
(days 10–13 of a gestation period of 16 days, estimated by subtraction
from the date of delivery) with 1×107 plaque-forming units (PFU) of
SV40. Control animals of similar gestationwere inoculated with 1.0 ml
of uninfected TC-7 cell lysate. Animals were housed in the biohazard
facility of the Center for Comparative Medicine at Baylor College of
Medicine. Animal protocols were approved by the Institutional Animal
Care and Use Committee and all care was in accordance with
established national guidelines as outlined in DHEW Publication No.
(NIH) 78-23.
Viruses
SV40 strains from different phylogenetic groups included: (i)
SVCPC (simple regulatory region), isolated from a brain tumor from a
4-year-old child (Lednicky et al., 1995a) and detected in various
human cancers (Arrington et al., 2004; Krieg and Scherer, 1984;
Lednicky et al., 1995a; Vilchez et al., 2002) and also found in Russian
oral poliovaccine used until the late 1970s (Cutrone et al., 2005); (ii)
SVPML-1 (complex regulatory region), a virus isolated from a patient
with progressive multifocal leukoencephalopathy (Weiner et al.,
1972); (iii) Baylor, an isolate recovered from a 1956 type 2 Sabin
poliovaccine (Melnick and Stinebaugh, 1962), with one variant having
a complex (Baylor-2E) and another a simple (Baylor-1E) regulatory
region (Lednicky and Butel, 1997, 2001); and (iv) reference strainFig. 2. Regulatory regions of SV40 viral isolates. The viral origin of DNA replication spanning
between nucleotides 40 and 103 is shown; the boxed number 72 is the 72-bp sequence with
rearranged enhancer region of SVPML-1 representedwith boxes labeled 38, 23, 20 and a shad
776. Modiﬁed from Lednicky and Butel (2001) and Stewart et al. (1998).SV40-776 variant 2E (complex regulatory region), isolated from an
adenovirus type 1 vaccine seed stock (Sweet and Hilleman, 1960). The
structures of the regulatory regions of these strains are shown (Fig. 2).
Virus stocks were prepared at 37 °C in TC-7 cells and were assayed
using a plaque assay in TC-7 cells (Butel et al., 1999b).
Sample preparation and DNA
Litters delivered by SV40-inoculated hamsters were sacriﬁced
between 1 and 21 days after birth and at 6 months post-parturition
(litters contained from 6 to 12 progeny). Organs harvested from
progeny hamsters included kidney, brain, spleen, and lung. Pregnant
hamsters were sacriﬁced from 2 to 6 days p.i., prior to delivery, and
placentas and fetuses were harvested. Maternal tissues collected
included kidney, spleen, lung, and blood.
Small pieces (∼100 mg, one to three separate slices) of harvested
tissues were minced, weighed, and incubated at 55 °C overnight with
proteinase K (Roche Diagnostics Corp., Indianapolis, IN) and nuclei
lysate solution (Promega Corp., Madison, WI). Protein was removed
and DNA was precipitated by isopropanol, resuspended in TE buffer
(pH 8.0), and stored at −20 °C. DNA from WBCs and plasma was
recovered using a proteinase K and phenol/chloroform protocol
(Lednicky and Butel, 1998).
Oligonucleotides and RQ-PCR analysis
SV40 was detected by RQ-PCR with primers and TaqMan probe
designed to detect sequences from the conserved N-terminal region of
the SV40 T-ag gene (McNees et al., 2005). An RQ-PCR assay tomeasure
the single copy hamster vimentin gene (Quax et al., 1983) was
developed in order to normalize SV40 T-ag gene copy numbers to cellnucleotides 5192 to 31 is represented by the box labeled ORI; the 21-bp repeat region
in the enhancer region that is duplicated in some laboratory-adapted strains, with the
ed box referring to nucleotides 252–263. Nucleotide numbers are based on that of SV40-
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absolute quantiﬁcation of SV40 T-ag and vimentin genes. Hamster
tissues were analyzed for SV40 T-ag and vimentin genes in separate
RQ-PCR assays. The standard curves were generated from 10-fold
dilutions of plasmid standards containing known input gene copy
numbers in each RQ-PCR assay. The amounts of SV40 T-ag and vi-
mentin genes in hamster tissues were determined from the appro-
priate standard curve. The SV40 T-ag genome copies per hamster cell
were calculated as the SV40 amount divided by one-half of the
vimentin amount, as the diploid hamster cell contains two copies of
the vimentin gene.
The plasmid pSV40-B2E was used as the SV40 standard in the RQ-
PCR assay (McNees et al., 2005). The vimentin plasmid standard was
constructed by PCR ampliﬁcation of the vimentin gene from hamster
tissue using primers VIM3 5′-ATAGAA TTC CGA CAAGGT GCG CTT CCT
GG-3′ and VIM4 5′-ATA GAA TTC CTC GCA GCC GCA TGA TGT CC-3′.
The PCR product was cloned using the TOPO TA cloning kit (Invitrogen,
Carlsbad, CA) and digested with EcoRI enzyme. The 206-bp fragment
of the hamster vimentin gene was inserted into a vector pUC19, and
the identity of the insert was conﬁrmed by restriction digestion and
sequence analysis. Plasmid stocks were prepared using the Endofree
Plasmid Maxi Kit (Qiagen, Valencia, CA) and concentrations were
determined by average A260 readings of multiple dilutions.
Primer and probes for the hamster vimentin gene RQ-PCR assay
were designed using Primer Express software from Applied Biosys-
tems. The forward and reverse primer sequences were 5′-TTC CTG
GAG CAG CAG AAC AA-3′ and 5′-TGC CCT GAC CCT TGA GTT G-3′. The
probe sequence was VIC-ATC CTG CTA GCC GAG CT-MGB. The target
sequences for the RQ-PCR primers and probe were within the 206-bp
fragment of the hamster vimentin gene in the plasmid standard.
RQ-PCR analyses were performed using the PRISM 7000 Sequence
Detection System (Applied Biosystems, Foster City, CA). 50-μl PCR
reactions were prepared using 900 nM of each primer, 100 nM of
TaqMan VIC-MGB-probe, and 25 μl of the 2× TaqMan Universal PCR
Master Mix (Applied Biosystems). Reactions were prepared using the
TaqMan PCR kit (Applied Biosystems) in PCR clean rooms. Test DNA
samples (10 μl) were added outside the PCR clean room facility after
tubes containing master mix and negative controls were sealed. After
the test DNA tubes were sealed, 10 μl of standard plasmid dilutions or
positive control samples were added in duplicate. RQ-PCR reaction
conditions for ampliﬁcation of SV40 and vimentin target genes were as
follows: 50 °C for 2 min, denaturing at 95 °C for 10 min, and 40 cycles
of denaturing at 95 °C for 15 s followed by annealing and extension at
60 °C for 1min. Ampliﬁcation datameasured as an increase in reporter
ﬂuorescencewere collected in real time and analyzed by the Sequence
Detection System software.
Detection of SV40 T-ag and neutralizing antibodies
Antibody directed against SV40 T-ag in hamster sera was assayed
by indirect immunoﬂuorescence staining of T-ag in SV40-transformed
cells (Butel and Ozbun, 1994). A plaque-reduction assay was used to
measure SV40 neutralizing antibodies (Butel et al., 1999b).
Statistical analysis
Categorical data are presented as percentages. The standard chi
square test was used to test differences between percentages. The
Fisher's exact test was used when one or more values were less than 5.
Generalized estimating equations (SPSS 16) were used to assess the
difference between simple and complex regulatory regions, tissue
type, and the interaction of these with respect to SV40 vertical
transmission rates. This model allows for the clustering of litter and
littermates within region and the repeated measures of tissue types
within offspring. This method assumed a binary logistic model andexchangeable correlation structure within offspring. A p-value less
than 0.05 was considered statistically signiﬁcant.
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